Helicobacter pylori in Children and Adolescents: Increase of Primary Clarithromycin Resistance, 1997–2000

Background The authors evaluate the prevalence of Helicobacter pylori resistance in 117 children and demonstrate the changes over a 4-year period. Methods In 117 children and adolescents, H. pylori-positive gastritis was revealed by diagnostic upper endoscopy. Biopsies from the antrum and body of the stomach were tested by histology, urease test, and culture. H. pylori was isolated using standard culture techniques, and susceptibility to amoxicillin, clarithromycin, and metronidazole was tested using the E-test (AB-Biodisk, Sweden). Results Endoscopy revealed gastric ulcers in 2 of 117 subjects, duodenal ulcers in 6 of 117, and erosive gastritis or duodenitis in 23 of 117. Almost all patients showed antral nodularity. Histology always showed chronic gastritis with different degrees of activity. During the 4-year study period, the authors noticed an increase of primary clarithromycin-resistant H. pylori strains, from 14.3% to 27.6% (mean, 20.3%). Metronidazole resistance varied between 5% and 25%. No resistance to amoxicillin was found. Conclusion Eradication of H. pylori should take place only after testing of susceptibility. The general use of clarithromycin in children should be restricted to better-defined indications. Resistance to clarithromycin of H. pylori may also become a future problem for the treatment of adults.

[1]  P. Malfertheiner,et al.  Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report , 2002, Alimentary pharmacology & therapeutics.

[2]  F. Gottrand,et al.  Helicobacter pylori in Children: Acquisition of Antimicrobial Resistance after an Initial Course of Treatment , 2001, Journal of Clinical Microbiology.

[3]  H. Oh,et al.  gyrA Mutations Associated with Quinolone Resistance in Bacteroides fragilis Group Strains , 2001, Antimicrobial Agents and Chemotherapy.

[4]  C. Dupont,et al.  Choosing triple therapy for Helicobacter pylori in children: antimicrobial resistance testing of first gastric biopsy culture may predict outcome. , 2001, Journal of pediatric gastroenterology and nutrition.

[5]  C. Dupont,et al.  High Levels of Resistance to Metronidazole and Clarithromycin in Helicobacter pylori Strains in Children , 2001, Journal of Clinical Microbiology.

[6]  P. Apfalter,et al.  In Vitro Activities of Linezolid Alone and in Combination with Amoxicillin, Clarithromycin, and Metronidazole againstHelicobacter pylori , 2000, Antimicrobial Agents and Chemotherapy.

[7]  X. Shi,et al.  Resistance of helicobacter pylori to metronidazole, tetracycline and amoxycillin. , 2000, The Journal of antimicrobial chemotherapy.

[8]  S. Koletzko,et al.  helicobacter pylori Infection in Children: A Consensus Statement , 2000 .

[9]  R. Spiller,et al.  Antimicrobial Susceptibility Testing ofHelicobacter pylori in a Large Multicenter Trial: the MACH 2 Study , 1999, Antimicrobial Agents and Chemotherapy.

[10]  D. Graham,et al.  Antibiotic resistance in Helicobacter pylori : Implications for therapy , 1998 .

[11]  F. Mégraud,et al.  Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. , 1998, Gastroenterology.

[12]  S. Suerbaum,et al.  Primary and Acquired Helicobacter pylori Resistance to Clarithromycin, Metronidazole, and Amoxicillin—Influence on Treatment Outcome , 1998, American Journal of Gastroenterology.

[13]  Vergis En,et al.  Macrolides are ideal for empiric therapy of community-acquired pneumonia in the immunocompetent host. , 1997 .

[14]  P Huovinen,et al.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. , 1997, The New England journal of medicine.

[15]  D. Graham,et al.  Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance. , 1996, The American journal of gastroenterology.

[16]  M. Nishio,et al.  Budd-Chiari syndrome attributed to protein C deficiency. , 1996, The American journal of gastroenterology.

[17]  J. Turnidge,et al.  Metronidazole resistance: A predictor of failure of Helicobacter pylori eradication by triple therapy , 1996, Journal of gastroenterology and hepatology.

[18]  J. Sloan,et al.  Helicobacter pylori: comparison of DNA fingerprints provides evidence for intrafamilial infection. , 1993, Gut.

[19]  P. Sherman,et al.  Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children. , 1987, The New England journal of medicine.

[20]  B. Marshall,et al.  UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS , 1983, The Lancet.

[21]  J. Rosenblatt,et al.  Antiparasitic agents. , 1999, Mayo Clinic proceedings.

[22]  B. Drumm,et al.  Clinical significance of Helicobacter infection in children. , 1998, British medical bulletin.

[23]  V. Yu,et al.  Macrolides are ideal for empiric therapy of community-acquired pneumonia in the immunocompetent host. , 1997, Seminars in respiratory infections.

[24]  H. Lamouliatte [How to eradicate Helicobacter pylori?]. , 1994, Gastroentérologie Clinique et Biologique.